Muhammad Adrish

682 total citations
41 papers, 418 citations indexed

About

Muhammad Adrish is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Muhammad Adrish has authored 41 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Physiology and 11 papers in Epidemiology. Recurrent topics in Muhammad Adrish's work include Asthma and respiratory diseases (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Respiratory and Cough-Related Research (5 papers). Muhammad Adrish is often cited by papers focused on Asthma and respiratory diseases (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Respiratory and Cough-Related Research (5 papers). Muhammad Adrish collaborates with scholars based in United States, India and United Kingdom. Muhammad Adrish's co-authors include Gilda Diaz‐Fuentes, Sridhar Chilimuri, Sindhaghatta Venkatram, Nicola A. Hanania, Nikhitha Mantri, Bharat Bajantri, Edison Cano Cevallos, Haozhe Sun, Wenyan Ji and Kristopher Attwood and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Muhammad Adrish

35 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Muhammad Adrish United States 9 141 134 102 100 77 41 418
Şermin Börekçi Türkiye 10 166 1.2× 50 0.4× 33 0.3× 136 1.4× 79 1.0× 60 397
Halise Akça Türkiye 11 45 0.3× 121 0.9× 70 0.7× 47 0.5× 35 0.5× 49 412
Safaa Hamdy Ahmad Saleh Egypt 9 64 0.5× 58 0.4× 101 1.0× 11 0.1× 27 0.4× 13 356
Januar Wibawa Martha Indonesia 10 56 0.4× 16 0.1× 29 0.3× 255 2.5× 22 0.3× 37 434
Anshul Jain India 6 141 1.0× 128 1.0× 120 1.2× 149 1.5× 18 0.2× 33 424
Emanuele Russo Italy 11 38 0.3× 26 0.2× 23 0.2× 85 0.8× 20 0.3× 56 512
Kulothungan Gunasekaran United States 12 159 1.1× 10 0.1× 14 0.1× 113 1.1× 58 0.8× 56 484
Hiba Masri‐Iraqi Israel 10 43 0.3× 22 0.2× 15 0.1× 38 0.4× 51 0.7× 31 526
Nicole Ali United States 12 152 1.1× 108 0.8× 25 0.2× 66 0.7× 16 0.2× 39 559
Isabel Campodarve Spain 12 40 0.3× 66 0.5× 48 0.5× 50 0.5× 9 0.1× 20 711

Countries citing papers authored by Muhammad Adrish

Since Specialization
Citations

This map shows the geographic impact of Muhammad Adrish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhammad Adrish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhammad Adrish more than expected).

Fields of papers citing papers by Muhammad Adrish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Muhammad Adrish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhammad Adrish. The network helps show where Muhammad Adrish may publish in the future.

Co-authorship network of co-authors of Muhammad Adrish

This figure shows the co-authorship network connecting the top 25 collaborators of Muhammad Adrish. A scholar is included among the top collaborators of Muhammad Adrish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Muhammad Adrish. Muhammad Adrish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adrish, Muhammad, et al.. (2025). Benralizumab Adherence Reduces Exacerbations and Exacerbation-related Medical Costs Among Patients With Severe Asthma: Results from the Zephyr-5 Study. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1390–A1390.
2.
Adrish, Muhammad, Ioana Agache, Angel Coz Yataco, et al.. (2025). Biologic Management in Severe Asthma for Adults. CHEST Journal. 169(2). 336–348.
3.
Phillips, Kimberley A., et al.. (2025). Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review. Journal of Personalized Medicine. 15(8). 370–370. 1 indexed citations
4.
Reddy, A. Mallikarjuna, et al.. (2025). Predicting weaning failure from invasive mechanical ventilation: The promise and pitfalls of clinical prediction scores. World Journal of Critical Care Medicine. 14(3). 108272–108272.
5.
Adrish, Muhammad, et al.. (2024). Biologics in Asthma. Immunology and Allergy Clinics of North America. 44(4). 751–763. 1 indexed citations
6.
Hanania, Nicola A., et al.. (2024). Personalized COPD Care: The Future of Precision-Based Therapies. Journal of Clinical Medicine. 13(21). 6339–6339. 4 indexed citations
7.
Adrish, Muhammad, et al.. (2023). Update on the Role of FeNO in Asthma Management. Diagnostics. 13(8). 1428–1428. 37 indexed citations
8.
Adrish, Muhammad, et al.. (2023). A rare case of isolated thoracic AL-amyloidoma causing complete atelectasis of the right lung. Respiratory Medicine Case Reports. 43. 101837–101837. 1 indexed citations
9.
Imayama, Ikuyo, et al.. (2023). Revisiting Asthma Obstructive Sleep Apnea Overlap: Current Knowledge and Future Needs. Journal of Clinical Medicine. 12(20). 6552–6552. 11 indexed citations
10.
Adrish, Muhammad & Praveen Akuthota. (2023). Approach to non-type 2 asthma. Respiratory Medicine. 216. 107327–107327. 7 indexed citations
11.
Mantri, Nikhitha, et al.. (2020). Thrombotic complications and anticoagulation in COVID-19 pneumonia: a New York City hospital experience. Annals of Hematology. 99(10). 2323–2328. 45 indexed citations
12.
Adrish, Muhammad, et al.. (2019). MYCOPLASMA AND LEGIONELLA PNEUMONIA PRESENTING AS BIVENTRICULAR FAILURE. CHEST Journal. 156(4). A669–A670. 1 indexed citations
13.
D’Agati, Vivette D., et al.. (2018). Pulmonary renal syndrome. Medicine. 97(23). e10954–e10954. 3 indexed citations
14.
Adrish, Muhammad, et al.. (2018). A rare case report of a saddle pulmonary embolism presenting with high grade fevers, responsive to anticoagulation. Medicine. 97(9). e0002–e0002. 2 indexed citations
15.
Zaidi, Bushra, et al.. (2018). A case report of Legionella and Mycoplasma pneumonia. Medicine. 97(40). e12650–e12650. 2 indexed citations
16.
Adrish, Muhammad, et al.. (2017). Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction. International Journal of COPD. Volume 12. 1183–1189. 34 indexed citations
17.
18.
Diaz‐Fuentes, Gilda, Bharat Bajantri, & Muhammad Adrish. (2016). Safety of Bronchoscopy in Patients with Echocardiographic Evidence of Pulmonary Hypertension. Respiration. 92(3). 182–187. 13 indexed citations
19.
Diaz‐Fuentes, Gilda, et al.. (2015). Use of Pro-BNP in the Intensive Care Unit to Predict Outcomes in Patients With Acute Exacerbation of COPD. CHEST Journal. 148(4). 675A–675A. 1 indexed citations
20.
Venkatram, Sindhaghatta, et al.. (2011). Vitamin D deficiency is associated with mortality in the medical intensive care unit. Critical Care. 15(6). R292–R292. 151 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026